Congenica Ltd.
A clinical genomic interpretation platform born from the Wellcome Sanger Institute, trusted by national programs like Genomics England and the NHS.
Last updated September 1, 2026
Overview
Congenica is a clinical genomic interpretation platform that originated from the Wellcome Sanger Institute. It has been involved in the UK's genomic medicine journey for over a decade, from the 100,000 Genomes Project to today's NHS GLHs. As part of the SeqOne family, it aims to bring greater capacity, innovation, and longevity to labs and clinicians. The company is trusted by laboratories in 35+ countries and delivers over 200,000 patient analyses annually.
History
Congenica was launched at the Wellcome Sanger Institute in 2012 to bridge the gap between genomic research and clinical practice. In 2015, it partnered at national scale. It has been at the heart of the UK's genomic medicine journey for over a decade, from the 100,000 Genomes Project to today's NHS GLHs. As part of the SeqOne family, it combines over a decade of NHS-validated pedigree with advanced AI-driven architecture.
Sources
Cite this profile: Cite the canonical profile. /brand-wiki/congenica-ltd-united-kingdom · Editorial policy · How profiles are compiled